Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Sep;73(3):702-705.
doi: 10.1016/j.jhep.2020.05.008. Epub 2020 May 12.

Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern Italy

Affiliations
Comment

Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern Italy

Angelo Di Giorgio et al. J Hepatol. 2020 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.

Comment on

References

    1. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. - PMC - PubMed
    1. Chai X., Hu L., Zhang Y., Han W., Lu Z., Ke A. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv. 2020 doi: 10.1101/2020.02.03.931766. - DOI
    1. D’Antiga L. Coronaviruses and immunosuppressed patients: the facts during the third epidemic. Liver Transpl. 2020;26(6):832–834. - PubMed
    1. Norsa L., Indriolo A., Sansotta N., Cosimo P., Greco S., D’Antiga L. Uneventful course in IBD patients during SARS-CoV-2 outbreak in northern Italy. Gastroenterology. 2020 doi: 10.1053/j.gastro.2020.03.062. - DOI - PMC - PubMed
    1. Lleo A., Invernizzi P., Lohse A.W., Aghemo A., Carbone M. Management of patients with autoimmune liver disease during COVID-19 pandemia. J Hepatol. 2020;73(2):453–455. - PMC - PubMed